An Observational Study to Evaluate Efficacy and Safety of Anti-TNF Agents in Patients with Moderate to Severe Psoriasis

@inproceedings{Ko2017AnOS,
  title={An Observational Study to Evaluate Efficacy and Safety of Anti-TNF Agents in Patients with Moderate to Severe Psoriasis},
  author={Erol Koç and Nilgun Solak and Burhan Engin and Nilgun Atakan and Serap Ozturkcan and Fatma Tuba Aydin and Mustafa Ozdemir and Ozer Arican and Emel B{\"u}lb{\"u}l Başkan and Mehmet Ali Gurer and Sedat Ozçelik and Neslihan Şendur and Mukadder Koçak and Hamdi Ozcan},
  year={2017}
}
Background: With the introduction of novel therapeutics, evaluation of efficacy becomes critical to prioritize therapeutic potential and minimize patient risk in psoriasis. Methods: A total of 86 patients with moderate to severe psoriasis receiving antitumor necrosis factor (TNF) treatment were included in a 24-week, national, multi-center, observational study to evaluate efficacy and safety of antiTNF agents. Efficacy was evaluated via psoriasis area and severity index (PASI) and static… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Chair of Guideline Group). British Association of Dermatologists’ guidelines for biologic interventions for psoriasis

CH Smith, AV Anstey, +3 authors DA Chandler
  • Br J Dermatol
  • 2009
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

European S3-guidelines on the systemic treatment of psoriasis vulgaris.

  • Journal of the European Academy of Dermatology and Venereology : JEADV
  • 2009
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL